Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 4,990 | 5,785 | 5,842 | 6,475 | 8,149 |
| Operating Income | -4,990 | -5,785 | -5,842 | -6,475 | -8,149 |
| Other Income | 2,664 | 8,596 | -5,088 | 2,160 | 5,091 |
| Pre-tax Income | -2,326 | 2,811 | -10,930 | -4,315 | -3,058 |
| Net Income Continuous | -2,326 | 2,811 | -10,930 | -4,315 | -3,058 |
| Minority Interests | -10 | -38 | -8 | -60 | -212 |
| Net Income | $-2,316 | $2,849 | $-10,922 | $-4,255 | $-2,846 |
| EPS Basic Total Ops | -162.50 | 104.56 | -1,225.00 | -262.24 | -174.83 |
| EPS Basic Continuous Ops | -158.32 | 189.74 | -745.57 | -306.64 | -227.60 |
| EPS Diluted Total Ops | -162.50 | 104.56 | -1,225.00 | -262.24 | -174.83 |
| EPS Diluted Continuous Ops | -158.32 | 189.74 | -745.57 | -306.64 | -227.60 |
| EBITDA(a) | $-4,919 | $-5,712 | $-5,786 | $-6,416 | $-8,092 |